← Back to patent-cliff list
头孢他啶
Tier C — Watch / tradeCeftazidime
葛兰素史克
Originator
1983
First approval
-
Expiry (public)
No sales data
Peak sales
化学药
Type
Targets：PBPs
Brand：Fortaz、Modacin、Tazicef、Fortam、Fortum、Pentacef、Ceptaz、Tazidime、Glazidim、Spectrum
Indications (approved)：细菌感染、革兰氏阳性细菌感染、革兰氏阴性细菌感染
Regional status
US
撤市
EU
-
China
批准上市
1993-01-01
Japan
-
Synthetic routes & intermediates
Routes not yet onboarded — the daily pipeline enriches by priority (approved small molecules first); this page updates automatically.
Frequently asked questions
What are the approved indications of Ceftazidime?
Approved indications include: 细菌感染, 革兰氏阳性细菌感染, 革兰氏阴性细菌感染.
When does the Ceftazidime patent expire?
No public expiry year is available for Ceftazidime yet; this page updates once verified.
How do I get a quote for Ceftazidime intermediates?
Open the CAS profile of the target intermediate from this page, or submit an RFQ directly — the CAS enters the matching flow automatically and the supply network responds with quotes.
Source: cross-verified data (structured fields only) · 2026-09-25